Healthcare provider profile · identity verified

Raymond Santos Roque, MD

Family Practice · OAKLAND, CA · NPI 1134329774

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	587	68
Amlodipine Besylate	Amlodipine Besylate	387	47
Losartan Potassium	Losartan Potassium	222	29
Fluticasone Propionate	Fluticasone Propionate	207	36
Lisinopril	Lisinopril	181	21
Trazodone Hcl	Trazodone Hcl	181	28
Levothyroxine Sodium	Levothyroxine Sodium	163	22
Furosemide	Furosemide	139	17
Metoprolol Succinate	Metoprolol Succinate	130	16
Tamsulosin Hcl	Tamsulosin Hcl	130	20
Gabapentin	Gabapentin	129	21
Eliquis	Apixaban	119	13
Pantoprazole Sodium	Pantoprazole Sodium	115	16
Clopidogrel	Clopidogrel Bisulfate	113	13
Omeprazole	Omeprazole	103	14
Metoprolol Tartrate	Metoprolol Tartrate	102	11
Donepezil Hcl	Donepezil Hcl	101	13
Finasteride	Finasteride	100	suppressed
Potassium Chloride	Potassium Chloride	100	13
Sertraline Hcl	Sertraline Hcl	94	13
Duloxetine Hcl	Duloxetine Hcl	92	13
Metformin Hcl	Metformin Hcl	85	11
Latanoprost	Latanoprost	83	12
Rosuvastatin Calcium	Rosuvastatin Calcium	78	13
Hydrochlorothiazide	Hydrochlorothiazide	71	suppressed
Jardiance	Empagliflozin	62	suppressed
Simvastatin	Simvastatin	62	suppressed
Allopurinol	Allopurinol	59	suppressed
Famotidine	Famotidine	58	13
Risperidone	Risperidone	58	suppressed
Memantine Hcl	Memantine Hcl	56	suppressed
Pravastatin Sodium	Pravastatin Sodium	54	suppressed
Trulicity	Dulaglutide	52	suppressed
Alendronate Sodium	Alendronate Sodium	49	suppressed
Metformin Hcl Er	Metformin Hcl	46	suppressed
Spironolactone	Spironolactone	41	suppressed
Atenolol	Atenolol	39	suppressed
Carvedilol	Carvedilol	39	suppressed
Divalproex Sodium	Divalproex Sodium	38	suppressed
Montelukast Sodium	Montelukast Sodium	38	suppressed
Insulin Aspart Flexpen	Insulin Aspart	36	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	34	suppressed
Timolol Maleate	Timolol Maleate	34	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	33	suppressed
Mirtazapine	Mirtazapine	31	suppressed
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Methotrexate	Methotrexate Sodium	29	suppressed
Ondansetron Odt	Ondansetron	28	suppressed
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	26	suppressed
Nebivolol Hcl	Nebivolol Hcl	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Bumetanide	Bumetanide	22	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	21	16
Chlorhexidine Gluconate	Chlorhexidine Gluconate	20	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Humira(Cf) Pen	Adalimumab	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Oxcarbazepine	Oxcarbazepine	20	suppressed
Sevelamer Hcl	Sevelamer Hcl	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	18	suppressed
Lurasidone Hcl	Lurasidone Hcl	18	suppressed
Premarin	Estrogens, Conjugated	18	suppressed
Ciclopirox	Ciclopirox	17	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	17	suppressed
Lactulose	Lactulose	17	suppressed
Levofloxacin	Levofloxacin	17	13
Memantine Hcl Er	Memantine Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Mirabegron Er	Mirabegron	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Jantoven	Warfarin Sodium	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Methenamine Hippurate	Methenamine Hippurate	15	suppressed
Potassium Citrate Er	Potassium Citrate	15	suppressed
Prednisone	Prednisone	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Benztropine Mesylate	Benztropine Mesylate	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Glipizide	Glipizide	14	suppressed
Motegrity	Prucalopride Succinate	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Alvesco	Ciclesonide	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Entecavir	Entecavir	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Rivastigmine	Rivastigmine Tartrate	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Estradiol	Estradiol	12	suppressed
Rhopressa	Netarsudil Mesylate	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Thalitone	Chlorthalidone	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Calcium Acetate	Calcium Acetate	11	suppressed
Dapagliflozin	Dapagliflozin Propanediol	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error